CC
TMO icon

ClearArc Capital’s Thermo Fisher Scientific TMO Stock Holding History

ClearArc Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1.22M Sell
3,741
-1,743
-32% -$529K 0.47% 50
2019
Q3 		$1.6M Buy
5,484
+50
+0.9% +$14.3K 0.46% 49
2019
Q2 		$1.6M Sell
5,434
-770
-12% -$212K 0.47% 48
2019
Q1 		$1.7M Sell
6,204
-180
-3% -$44.8K 0.46% 55
2018
Q4 		$1.43M Sell
6,384
-2,926
-31% -$687K 0.43% 56
2018
Q3 		$2.27M Buy
9,310
+68
+0.7% +$15.6K 0.3% 84
2018
Q2 		$1.91M Buy
9,242
+71
+0.8% +$15.1K 0.27% 92
2018
Q1 		$1.89M Buy
9,171
+60
+0.7% +$12.6K 0.29% 87
2017
Q4 		$1.73M Buy
9,111
+51
+0.6% +$9.77K 0.23% 98
2017
Q3 		$1.71M Buy
9,060
+188
+2% +$34K 0.26% 91
2017
Q2 		$1.55M Buy
8,872
+49
+0.6% +$8.23K 0.25% 101
2017
Q1 		$1.35M Sell
8,823
-60
-0.7% -$9.17K 0.23% 110
2016
Q4 		$1.25M Sell
8,883
-88
-1% -$13K 0.23% 113
2016
Q3 		$1.43M Buy
8,971
+32
+0.4% +$4.93K 0.27% 96
2016
Q2 		$1.32M Sell
8,939
-47
-0.5% -$6.94K 0.26% 98
2016
Q1 		$1.27M Sell
8,986
-45
-0.5% -$6.03K 0.27% 96
2015
Q4 		$1.28M Buy
9,031
+85
+1% +$11.3K 0.27% 97
2015
Q3 		$1.09M Sell
8,946
-159
-2% -$20.7K 0.23% 118
2015
Q2 		$1.18M Buy
9,105
+1,041
+13% +$136K 0.22% 124
2015
Q1 		$1.08M Buy
8,064
+89
+1% +$11.5K 0.22% 130
2014
Q4 		$999K Buy
7,975
+189
+2% +$23K 0.2% 142
2014
Q3 		$948K Buy
7,786
+174
+2% +$21.2K 0.21% 140
2014
Q2 		$898K Sell
7,612
-477
-6% -$56.1K 0.21% 139
2014
Q1 		$973K Buy
8,089
+765
+10% +$91K 0.24% 126
2013
Q4 		$816K Buy
7,324
+121
+2% +$12K 0.21% 138
2013
Q3 		$664K Sell
7,203
-213
-3% -$19.3K 0.19% 152
2013
Q2 		$628K Buy
+7,416
New +$617K 0.17% 157

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearArc Capital's TMO Position: Q4 2019 in Review

ClearArc Capital reduced its Thermo Fisher Scientific (TMO) stake by 32% in Q4 2019, selling an estimated $529K and leaving 3,741 shares worth $1.22M. The position accounts for 0.47% of the portfolio, ranked #50.

ClearArc Capital first reported a position in TMO in Q2 2013 and has held it in 27 quarters since. The position peaked at $2.27M in Q3 2018. 1,679 funds tracked by Wall St. Rank hold TMO as of Q4 2019.

  • ClearArc Capital held 3,741 shares of Thermo Fisher Scientific worth $1.22M as of Q4 2019.
  • ClearArc Capital sold 1,743 Thermo Fisher Scientific shares in Q4 2019, an estimated $529K.
  • Thermo Fisher Scientific made up 0.47% of ClearArc Capital's portfolio in Q4 2019, its #50 holding.
  • ClearArc Capital first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 27 quarters since.
  • ClearArc Capital's Thermo Fisher Scientific position peaked at $2.27M in Q3 2018.
  • 1,679 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2019.

Based on ClearArc Capital's 13F filing for Q4 2019, filed 14 Feb 2020.